Royalty Pharma plc (RPRX)
NASDAQ: RPRX · Real-Time Price · USD
36.67
+0.08 (0.22%)
At close: Jul 25, 2025, 4:00 PM
36.84
+0.17 (0.45%)
After-hours: Jul 25, 2025, 7:41 PM EDT
Royalty Pharma Market Cap
Royalty Pharma has a market cap or net worth of $20.62 billion as of July 25, 2025. Its market cap has increased by 77.93% in one year.
Market Cap
20.62B
Enterprise Value
27.13B
1-Year Change
77.93%
Ranking
Category
Stock Price
$36.67
Market Cap Chart
Since June 16, 2020, Royalty Pharma's market cap has increased from $15.76B to $20.62B, an increase of 30.81%. That is a compound annual growth rate of 5.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2025 | 15.42B | 36.03% |
| Dec 31, 2024 | 11.33B | -9.30% |
| Dec 29, 2023 | 12.50B | -28.31% |
| Dec 30, 2022 | 17.43B | 1.85% |
| Dec 31, 2021 | 17.12B | -11.89% |
| Dec 31, 2020 | 19.43B | 23.26% |
| Jun 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 723.06B |
| Johnson & Johnson | 407.97B |
| AbbVie | 337.08B |
| Novo Nordisk | 313.06B |
| UnitedHealth Group | 252.71B |
| AstraZeneca | 228.91B |
| Novartis AG | 227.81B |
| Abbott Laboratories | 218.59B |